Chicken Flu Research Today is a free monthly online journal that collates and summarizes the latest research about Chicken Flu, including details on avian influenza, pandemic, symptoms, vaccines.

Volume 6 (2009), Issue 6 (June)

1. Predicting the anticipated emotional and behavioral responses to an avian flu outbreak.
   Am J Infect Control, 37(5): 371-80. [Abstract] [Full-text]
2. Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.
   J Biol Chem, 284(23): 15729-38. [Abstract] [Full-text]
3. H5N1 avian influenza in cats. ABCD guidelines on prevention and management.
   J Feline Med Surg, 11(7): 615-8. [Abstract] [Full-text]
4. Extending the environmental risk assessment for oseltamivir (Tamiflu) under pandemic use conditions to the coastal marine compartment.
   Environ Int, 35(6): 931-6. [Abstract] [Full-text]
5. A computational Grid framework for immunological applications.
   Philos Transact A Math Phys Eng Sci, 367(1898): 2705-16. [Abstract] [Full-text]
6. The Role of Swine in the Generation of Novel Influenza Viruses.
   Zoonoses Public Health. [Abstract] [Full-text]
7. Emerging Infections: A Tribute to the One Medicine, One Health Concept.
   Zoonoses Public Health. [Abstract] [Full-text]
8. Characterization of an avian influenza virus H5N1 Egyptian isolate.
   J Virol Methods, 159(2): 244-50. [Abstract] [Full-text]
9. Evaluation of a commercial blocking enzyme-linked immunosorbent assay to detect avian influenza virus antibodies in multiple experimentally infected avian species.
   Clin Vaccine Immunol, 16(6): 824-9. [Abstract] [Full-text]
10. Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1.
    Future Microbiol, 4: 503-5. [Abstract] [Full-text]
11. A single substitution in amino acid 184 of the NP protein alters the replication and pathogenicity of H5N1 avian influenza viruses in chickens.
    Arch Virol, 154(6): 969-79. [Abstract] [Full-text]
12. Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR.
    Arch Virol, 154(6): 939-44. [Abstract] [Full-text]
13. Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses.
    Arch Virol, 154(6): 945-57. [Abstract] [Full-text]
14. Genetic and Antigenic Evolution of Swine Influenza Viruses in Europe and Evaluation of Their Zoonotic Potential.
    Zoonoses Public Health. [Abstract] [Full-text]
15. Recent advances in tropical medicine.
    Trans R Soc Trop Med Hyg, 103(7): 647-52. [Abstract] [Full-text]
16. A geographical spread of vaccine-resistance in avian influenza epidemics.
    J Theor Biol, 259(2): 219-28. [Abstract] [Full-text]
17. Towards a sane and rational approach to management of Influenza H1N1 2009.
    Virol J, 6: 51. [Abstract] [Full-text]
18. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites.
    Biol Direct, 4: 18; discussion 18. [Abstract] [Full-text]
19. Galactose-conjugates of the oseltamivir pharmacophore--new tools for the characterization of influenza virus neuraminidases.
    Org Biomol Chem, 7(12): 2570-5. [Abstract] [Full-text]
20. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
    Vaccine, 27(31): 4161-8. [Abstract] [Full-text]
21. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.
    Vaccine, 27(31): 4187-95. [Abstract] [Full-text]
22. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis.
    Virol J, 6: 67. [Abstract] [Full-text]
23. Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses.
    PLoS One, 4(6): e5788. [Abstract] [Full-text]
24. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice.
    Vet Microbiol, 138(1): 85-91. [Abstract] [Full-text]
25. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.
    J Virol, 83(13): 6566-77. [Abstract] [Full-text]
26. Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice.
    J Virol, 83(13): 6673-80. [Abstract] [Full-text]
27. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.
    Mol Immunol, 46(11): 2210-7. [Abstract] [Full-text]
28. High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: a possible immune pressure-driven cross-species transmission.
    Biochem Biophys Res Commun, 385(3): 402-7. [Abstract] [Full-text]
29. Prevention and Control of Infectious Diseases with Pandemic Potential: The EU-Project SARSControl.
    Gesundheitswesen, 71(6): 351-357. [Abstract] [Full-text]
30. Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase.
    EMBO J, 28(12): 1803-11. [Abstract] [Full-text]
31. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus.
    J Infect Dis, 200(2): 181-90. [Abstract] [Full-text]
32. Proteolytic bacteria in the lower digestive tract of poultry may affect avian influenza virus pathogenicity.
    Poult Sci, 88(7): 1388-93. [Abstract] [Full-text]
33. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.
    N Engl J Med, 360(25): 2616-25. [Abstract] [Full-text]
34. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
    J Comput Chem, 30(11): 1654-63. [Abstract] [Full-text]
35. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.
    Clin Infect Dis, 49(2): 279-90. [Abstract] [Full-text]
36. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Arch Virol. [Abstract] [Full-text]
37. Infection and replication of avian influenza H5N1 virus in an infected human.
    Virus Genes, 39(1): 76-80. [Abstract] [Full-text]
38. Comparative analysis between a low pathogenic and a high pathogenic influenza H5 hemagglutinin in cell entry.
    Virol J, 6: 76. [Abstract] [Full-text]
39. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.
    Virol J, 6: 74. [Abstract] [Full-text]
40. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.
    Antimicrob Agents Chemother, 53(7): 3088-96. [Abstract] [Full-text]
41. Ocular infection of mice with influenza A (H7) viruses: a site of primary replication and spread to the respiratory tract.
    J Virol, 83(14): 7075-84. [Abstract] [Full-text]
42. Environmental transmission of low pathogenicity avian influenza viruses and its implications for pathogen invasion.
    Proc Natl Acad Sci U S A, 106(25): 10365-9. [Abstract] [Full-text]
43. What is the optimal therapy for patients with H5N1 influenza?
    PLoS Med, 6(6): e1000091. [Abstract] [Full-text]
44. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome.
    PLoS One, 4(6): e6051. [Abstract] [Full-text]
45. Amplification of four genes of influenza A viruses using a degenerate primer set in a one step RT-PCR method.
    J Virol Methods, 160(1): 163-6. [Abstract] [Full-text]
46. Rapid haemagglutinin subtyping and pathotyping of avian influenza viruses by a DNA microarray.
    J Virol Methods, 160(1): 200-5. [Abstract] [Full-text]
47. Interdigitated array microelectrode based impedance immunosensor for detection of avian influenza virus H5N1.
    Talanta, 79(2): 159-64. [Abstract] [Full-text]
48. Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza.
    J Clin Virol, 45(3): 200-2. [Abstract] [Full-text]
49. Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks.
    J Clin Virol, 45(3): 185-90. [Abstract] [Full-text]
50. Development of a real-time RT-PCR for the detection of swine-lineage influenza A (H1N1) virus infections.
    J Clin Virol, 45(3): 196-9. [Abstract] [Full-text]
51. The 2009 H1N1 influenza outbreak in its historical context.
    J Clin Virol, 45(3): 174-8. [Abstract] [Full-text]

© 2004-2012 Chicken Flu Research Today. All Rights Reserved.